TWD 20.6
(-1.2%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 287.43 Million | 398.4 Million | 132.62 Million | 197.55 Million | - |
Net Income | 53.45 Million | 293.97 Million | 136.64 Million | 108.81 Million | - |
Depreciation & Amortization | 174.66 Million | 157.96 Million | 137.7 Million | 122.77 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 118.24 Million | 18.5 Million | -91.91 Million | -17.8 Million | - |
Other non-cash items | 11.81 Million | 9.2 Million | 5.3 Million | 6.27 Million | - |
Investing Cash Flow | -227.82 Million | -349.04 Million | -339.01 Million | -203 Million | - |
Investments in PPE | -243.64 Million | -391.49 Million | -362.24 Million | -209.41 Million | - |
Acquisitions | 15.77 Million | - | - | - | - |
Investment purchases | - | - | -228.45 Million | -198.53 Million | -42.97 Million |
Sales/Maturities of investments | - | 11.32 Million | 250.26 Million | 202.54 Million | - |
Other Investing Activities | 45 Thousand | -222 Thousand | 1.41 Million | 2.4 Million | - |
Financing Cash Flow | 116.07 Million | 12.64 Million | 102.71 Million | 26.72 Million | - |
Debt repayment | -142 Million | -72.29 Million | -166.42 Million | -76.05 Million | - |
Dividends payments | -22.3 Million | -55.75 Million | -60.39 Million | -46.46 Million | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -3.63 Million | -131 Thousand | 131 Thousand | - | - |
Accounts receivables | 185.7 Million | - | - | - | - |
Accounts payables | -106.16 Million | - | - | - | - |
Inventory | 107.43 Million | 31.17 Million | -126.8 Million | -43.28 Million | - |
Other working capital | -174.9 Million | - | - | - | - |
Cash at beginning of period | 617.29 Million | 534.62 Million | 660.77 Million | 648.56 Million | - |
Cash at end of period | 787.35 Million | 617.29 Million | 534.62 Million | 660.77 Million | - |
Capital Expenditure | -243.64 Million | -391.49 Million | -362.24 Million | -209.41 Million | - |
Effect of forex changes on cash | -5.62 Million | 20.67 Million | -22.48 Million | -9.05 Million | - |
Net cash flow / Change in cash | 170.05 Million | 82.67 Million | -126.15 Million | 12.21 Million | - |
Free Cash Flow | 43.79 Million | 6.9 Million | -229.61 Million | -11.86 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 22.33 Million | -18.54 Million | 53.45 Million | -27.64 Million | 18.48 Million | 20.3 Million |
Depreciation & Amortization | 47.46 Million | 46.37 Million | 174.66 Million | 44.36 Million | 43.88 Million | 43.08 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -28.9 Million | -6.68 Million | 118.24 Million | 65.18 Million | -51.59 Million | 72.11 Million |
Other non-cash items | 15.09 Million | 3.24 Million | 11.81 Million | 1.42 Million | 4.14 Million | 2.43 Million |
Investing Cash Flow | 12.4 Million | -79.88 Million | -227.82 Million | -56.09 Million | -64.3 Million | -66.62 Million |
Investments in PPE | -59.05 Million | -106.51 Million | -243.64 Million | -64.17 Million | -68.36 Million | -55.17 Million |
Acquisitions | 70.75 Million | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 704 Thousand | 20 Thousand | 45 Thousand | 65 Thousand | -117 Thousand | 75 Thousand |
Financing Cash Flow | -52.18 Million | 37.96 Million | 116.07 Million | -48.01 Million | 31.94 Million | 90.6 Million |
Debt repayment | -51.87 Million | -38.35 Million | -142 Million | -24.91 Million | -32.86 Million | -91.54 Million |
Dividends payments | - | - | -22.3 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -315 Thousand | - | - | - | - | - |
Accounts receivables | -33.3 Million | - | - | - | - | - |
Accounts payables | 16.97 Million | - | - | - | - | - |
Inventory | -12.19 Million | 10.07 Million | 107.43 Million | -9.6 Million | 19.42 Million | 41.85 Million |
Other working capital | -374.99 Thousand | - | - | - | - | - |
Cash at beginning of period | 793.79 Million | 787.35 Million | 617.29 Million | 812.53 Million | 829.87 Million | 731.53 Million |
Cash at end of period | 751.88 Million | 793.79 Million | 787.35 Million | 787.35 Million | 812.53 Million | 829.87 Million |
Capital Expenditure | -59.05 Million | -106.51 Million | -243.64 Million | -64.17 Million | -68.36 Million | -55.17 Million |
Effect of forex changes on cash | 3.28 Million | 14 Million | -5.62 Million | -15.75 Million | 10.72 Million | 292 Thousand |
Net cash flow / Change in cash | -41.91 Million | 6.44 Million | 170.05 Million | -25.18 Million | -17.33 Million | 98.33 Million |
Free Cash Flow | -64.46 Million | -72.16 Million | 43.79 Million | 30.5 Million | -64.06 Million | 18.88 Million |
IVFH
LLAP
8081
1929
SUPN
GMEXICOB